Inflammatory chemokine receptors regulate CD8+T cell contraction and memory generation following infection by Kohlmeier, Jacob E. et al.
Article
The Rockefeller University Press $30.00
J. Exp. Med. Vol. 208 No. 8 1621-1634
www.jem.org/cgi/doi/10.1084/jem.20102110
1621
During an acute peripheral infection, antigen-
bearing dendritic cells migrate to local draining 
lymphoid organs, where they initiate pathogen-
specific T cell responses (Legge and Braciale, 
2003; Allan et al., 2006). After antigen encoun-
ter, proliferation, and differentiation, effector 
CD8+ T cells enter the circulation and are di-
rected to the infected site through a complex 
series of interactions involving adhesion mole-
cules and chemokine receptors. Once in in-
flamed tissues, effector T cells follow chemotactic 
gradients to infected cells, and arrest their mi-
gration once they reencounter antigen to exert 
their effector functions on infected targets 
(Dustin et al., 1997; Bromley et al., 2008). 
After pathogen clearance, the effector CD8+ 
T cell pool undergoes extensive contraction, dur-
ing which 95% of pathogen-specific T cells die 
by apoptosis and the remaining 5% survive to 
become long-lived memory cells (Williams and 
Bevan, 2007). The ability to skew this ratio in 
favor of T cell memory has broad implications 
for vaccinology, and therefore the signals that 
govern which cells are fated to undergo apop-
tosis and which cells will survive to persist as 
memory have been the subject of intense study.
Currently, a preponderance of evidence sup-
ports an important role for the inflammatory 
microenvironment in controlling effector ver-
sus memory cell–fate decisions (Kolumam et al., 
2005; Harty and Badovinac, 2008; Prlic and 
Bevan, 2008; Obar and Lefrançois, 2010). Speci-
fically, studies have shown that effector T cells 
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The development of T cell memory from naive precursors is influenced by molecular cues 
received during T cell activation and differentiation. In this study, we describe a novel role 
for the chemokine receptors CCR5 and CXCR3 in regulating effector CD8+ T cell contrac-
tion and memory generation after influenza virus infection. We find that Ccr5/ Cxcr3/ 
cells show markedly decreased contraction after viral clearance, leading to the establish-
ment of massive numbers of memory CD8+ T cells. Ccr5/ Cxcr3/ cells show reduced 
expression of CD69 in the lung during the peak of infection, which coincides with differen-
tial localization and the rapid appearance of memory precursor cells. Analysis of single 
chemokine receptor–deficient cells revealed that CXCR3 is primarily responsible for this 
phenotype, although there is also a role for CCR5 in the enhancement of T cell memory. 
The phenotype could be reversed by adding exogenous antigen, resulting in the activation 
and contraction of Ccr5/ Cxcr3/ cells. Similar results were observed during chronic 
Mycobacterium tuberculosis infection. Together, the data support a model of memory CD8+ 
T cell generation in which the chemokine-directed localization of T cells within infected 
tissues regulates antigen encounter and controls the extent of CD8+ T cell activation and 
differentiation, which ultimately regulates effector versus memory cell fate decisions.
© 2011 Kohlmeier et al. This article is distributed under the terms of an At-
tribution–Noncommercial–Share Alike–No Mirror Sites license for the first six 
months after the publication date (see http://www.rupress.org/terms). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
T
h
e 
Jo
u
rn
al
 o
f 
E
xp
er
im
en
ta
l 
M
ed
ic
in
e
o
n
 February 10, 2017
D
ow
nloaded from
 
Published July 25, 2011
/content/suppl/2011/07/22/jem.20102110.DC1.html 
Supplemental Material can be found at:
1622 CCR5 and CXCR3 regulate T cell memory generation | Kohlmeier et al.
CD8+ T cell memory. In the present study, we used murine 
models of influenza virus and Mycobacterium tuberculosis (Mtb) 
infection to investigate the role of the chemokine receptors 
CCR5 and CXCR3 in the generation of T cell memory. 
We find that Ccr5/ Cxcr3/ effector CD8+ T cells show 
dramatically impaired activation within infected tissues com-
pared with wild-type (WT) cells, resulting in attenuated con-
traction and greatly enhanced memory generation. The 
enhanced potential of virus-specific Ccr5/ Cxcr3/ cells 
to progress to memory was caused by their inability to re-
encounter antigen in the lung, as the addition of exogenous 
antigen was sufficient to induce the activation and contraction 
of virus-specific Ccr5/ Cxcr3/ T cells in the lung. These 
data demonstrate a novel role for inflammatory chemokine 
receptors in controlling effector versus memory cell fate deci-
sions during infection.
RESULTS
Enhanced memory generation in CD8+ T cells lacking both 
CCR5 and CXCR3
Inflammatory chemokine receptors, such as CCR5 and 
CXCR3, play a crucial role in directing the migration of 
lymphocytes to sites of inflammation. Previous studies have 
shown that these receptors can impact recruitment to the 
lung during steady-state conditions and after infection 
(Galkina et al., 2005; Fadel et al., 2008; Lindell et al., 2008; 
Kohlmeier et al., 2009). However, the role of these receptors 
on the generation of T cell memory after the resolution of 
infection has not been thoroughly addressed. One difficulty 
in assessing the impact of CCR5 and CXCR3 on memory 
T cell generation is that gene-deficient mice show different sus-
ceptibilities to influenza infection (Fig. S1). To circumvent 
this issue, we generated cohorts of mixed BM chimeras in 
which a population of T cells lacking one or both of these 
chemokine receptors could be directly compared with WT 
cells in the same animal (Fig. 1 A). After primary infection 
with x31 influenza, similar frequencies of influenza nucleo-
protein (FluNP)366-374Db–specific effector CD8+ T cells were 
elicited between WT and Ccr5/ (Fig. 1 B), Cxcr3/ (Fig. 1 C), 
or Ccr5/ Cxcr3/ (Fig. 1 D) T cell populations. However, 
60 d after x31 infection, there was a significant difference in the 
frequency of FluNP366-374Db-specific Cxcr3/ cells (Fig. 1 E, 
blue line) and Ccr5/ Cxcr3/ cells (Fig. 1 E, red line) com-
pared with WT cells within the same host. This difference 
was greatly enhanced after secondary challenge with PR8 
influenza, particularly among Ccr5/ Cxcr3/ cells, as the 
FluNP366-374Db-specific population accounted for nearly 40% 
of the total polyclonal CD8+ T cell pool. Strikingly, this large 
FluNP366-374Db-specific population was maintained into sec-
ondary memory such that 20% of the total polyclonal CD8+ 
T cell pool was specific for this epitope even at 270 d after 
challenge. A similar trend was observed with Cxcr3/ cells, 
although the difference was not as dramatic, and Ccr5/ cells 
showed no difference in the frequency of FluNP366-374Db-specific 
effector or memory CD8+ T cells. Infection of intact gene-
deficient mice with the less pathogenic x31 influenza virus, 
require inflammatory signals for their clonal expansion and 
differentiation, and the absence of inflammation during prim-
ing results in anergy or deletion (Badovinac et al., 2002; 
Redmond and Sherman, 2005; Joshi et al., 2007). However, 
too much inflammation, such as high levels of the proinflam-
matory cytokines IL-12 and IFN-, favors the generation of 
terminally differentiated effector CD8+ T cells (Badovinac 
et al., 2005; Pearce and Shen, 2007). In contrast to inflamma-
tory signals, homeostatic cytokines such as IL-7 and IL-15 
promote the formation of memory CD8+ T cells after acute 
infection (Schluns et al., 2000; Rubinstein et al., 2008; Sandau 
et al., 2010). The ability of homeostatic cytokines to enhance 
memory CD8+ T cell formation is consistent with the idea 
that the IL-7Rhi effector subset present during an acute in-
fection preferentially gives rise to long-lived memory CD8+ 
T cells (Kaech et al., 2003; Huster et al., 2004). It should be 
noted, however, that enforced IL-7R expression does not 
alter the fate of terminally differentiated effector cells, sug-
gesting that IL-7 signaling by itself is not sufficient (Hand et al., 
2007). Nevertheless, it is clear that the strength and duration 
of the inflammatory environment can alter the ratio of 
IL-7Rhi memory precursor effector cells (MPECs) to IL-7Rlo 
short lived effector cells (SLECs), and ultimately influence the 
quality and magnitude of the memory CD8+ T cell pool.
During influenza virus infection, effector CD8+ T cells 
initially primed in the lung-draining lymph nodes traffic to 
the lung to mediate viral clearance (Kohlmeier and Woodland, 
2009). Once in the lung, effector CD8+ T cells are sub-
jected to a highly inflammatory environment, and can re-
encounter antigen presented by local dendritic cells, infected 
epithelial cells, and other cells. These interactions can drive 
additional T cell proliferation and differentiation, which con-
tribute to the magnitude of the effector T cell response 
(McGill and Legge, 2009). In addition, the interaction of ef-
fector CD8+ T cells and dendritic cells in the lung promotes 
T cell survival via IL-15 transpresentation (McGill et al., 
2010). As these studies demonstrate, antigen-specific T cells 
continue to receive additional instruction after arriving in the 
lung, but it is unclear how these instructions influence the 
generation of T cell memory after viral clearance.
Several chemokine receptors have been shown to play a 
role in the accumulation of effector T cells in the lung. CCR5 
was shown to be important for the migration of circulating 
effector T cells into the interstitium under steady-state condi-
tions (Galkina et al., 2005). During acute respiratory virus in-
fection, effector T cell migration to the inflamed lung was 
dependent on CXCR3, with only a minor role for CCR5 
(Fadel et al., 2008; Lindell et al., 2008; Kohlmeier et al., 
2009). However, CCR5 does have a role in memory T cell 
migration to the lung airways during respiratory virus chal-
lenge, suggesting it may be important for the localization of 
cells to different compartments in the inflamed lung (Kohlmeier 
et al., 2008). Considering the role of these receptors in guid-
ing T cells to infected sites, and the impact this may have in 
determining effector versus memory cell fate decisions, it is 
likely that chemokine receptors can influence generation of 
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As shown in Fig. 2, Ccr5/ Cxcr3/ mice had significantly 
lower viral loads than WT mice at day 2 after challenge, 
which is indicative of an increased number of memory T cells 
present in the lung in Ccr5/ Cxcr3/ mice at the time of 
challenge (Fig. 2 A). However, there was no significant dif-
ference in viral titers between WT and Ccr5/ Cxcr3/ 
mice on days 4, 6, or 8 after infection, which is consistent 
with the rapid recruitment of WT T cells, but not Ccr5/ 
Cxcr3/ T cells, to the lung in response to inflammation 
(Kohlmeier and Woodland, 2009). However, the enhanced 
which all mice survive, gave similarly enhanced memory 
T cell numbers compared with WT mice (Fig. S2). In addition, 
memory T cells generated after x31 influenza clearance were 
able to protect from a lethal PR8 influenza challenge, regard-
less of whether they lacked CCR5, CXCR3, or both chemo-
kine receptors (Fig. S2).
To determine whether the increased number of memory 
T cells in Ccr5/ Cxcr3/ mice correlated with enhanced 
protection compared with WT mice, we measured viral titers 
of x31 influenza-immune mice after PR8 influenza challenge. 
Figure 1. CD8+ T cells deficient in CCR5 and CXCR3 dominate the primary and secondary memory cell pool. (A) Mixed BM chimeras were gen-
erated and infected with influenza viruses as indicated to assess primary and secondary T cell responses. (B–D) Representative FluNP366-374Db tetramer 
staining from the spleen of Ccr5/ (B), Cxcr3/ (C), or Ccr5/ Cxcr3/ (D) mixed BM chimeras at the indicated times after primary and secondary 
influenza infection. Plots shown are gated on WT or chemokine receptor–deficient CD8+ T cells, and the numbers show the frequency of FluNP366-374Db-
specific cells within that gate. (E) The frequency of FluNP366-374Db-specific WT (black), Ccr5/ (green, top graph), Cxcr3/ (blue, middle graph), or Ccr5/ 
Cxcr3/ (red, bottom graph) cells in the spleen over time (mean ± SD; *, P < 0.05; **, P < 0.005; ***, P < 0.0005). The data are representative of two inde-
pendent experiments with five mice per time point.
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of the Ccr5/ Cxcr3/ population at day 60 after infection 
was uniformly CD27hi, CD127hi, and KLRG1lo, indicating 
that these cells are indeed resting memory cells and not 
merely terminally differentiated effector T cells that had sur-
vived contraction (Fig. 3 C). Furthermore, Ccr5/ Cxcr3/ 
cells show comparable cytokine and granzyme responses to 
WT cells during both primary and secondary responses (Fig. S3). 
Thus, the enhanced memory generation by cells lacking in-
flammatory chemokine receptors is observed in both lym-
phoid and nonlymphoid tissues and is caused by greatly reduced 
contraction after influenza infection.
Ccr5/ Cxcr3/ cells have limited access to antigen  
in the lung and decreased caspase activity
Contraction of the influenza-specific effector CD8+ T cell 
pool typically occurs immediately after viral clearance be-
tween days 9–11 after infection (Kedzierska et al., 2006). 
Because we observed that Ccr5/ Cxcr3/ FluNP366-374Db-
specific cells began to overtake their WT counterparts around 
this time (Fig. 3 A), we examined the FluNP366-374Db-specific 
population in greater detail after viral clearance. As shown in 
Fig. 4, A and B, whereas the frequency of WT FluNP366-374Db-
specific cells did not change between 10–14 d after infec-
tion, the frequency of Ccr5/ Cxcr3/ FluNP366-374Db-specific 
cells continued to rise in all tissues after viral clearance. 
One explanation for this difference is that Ccr5/ Cxcr3/ 
cells continued to proliferate at a high rate after viral clear-
ance. To test this hypothesis, we assessed BrdU incorporation in 
WT and Ccr5/ Cxcr3/ FluNP366-374Db-specific cells in 
memory T cell response in Ccr5/ Cxcr3/ mice was also 
associated with increased immunopathology during the early 
stage of the recall response (Fig. 2, B and C), demonstrating 
that there is a tradeoff between more rapid viral clearance and 
accelerated pathology. Together, these data show that T cells 
lacking CXCR3 display increased memory generation after 
influenza infection, and that this increase in T cell memory is 
greatly enhanced in cells lacking both CCR5 and CXCR3. 
In addition, the increased T cell memory in Ccr5/ Cxcr3/ 
mice is functional, decreasing viral loads during the early 
stages of a challenge infection while concomitantly resulting 
in more rapid immunopathology.
As the enhancement in T cell memory was most dramatic 
in the absence of both chemokine receptors, we chose to 
focus our studies on Ccr5/ Cxcr3/ cells. To investigate 
the expansion and contraction of Ccr5/ Cxcr3/ cells 
after influenza infection in greater detail, we analyzed the 
FluNP366-374Db-specific response in multiple tissues from mixed 
BM chimeras over time. As shown in Fig. 3 A, although the 
number of FluNP366-374Db-specific WT (black line) and Ccr5/ 
Cxcr3/ (red line) CD8+ T cells is similar in many tissues at 
day 8 after infection, the number of Ccr5/ Cxcr3/ 
FluNP366-374Db-specific cells was significantly greater than 
the number of WT FluNP366-374Db-specific T cells in all tis-
sues throughout the memory phase. Interestngly, contraction 
of the effector T cell pool that normally occurs after patho-
gen clearance was greatly impaired in Ccr5/ Cxcr3/ 
FluNP366-374Db-specific cells (Fig. 3 B), which explains the 
enhanced generation of memory. In addition, the phenotype 
Figure 2. Increased CD8+ T cell memory 
in Ccr5/ Cxcr3/ mice results in de-
crease viral titers and enhanced immuno-
pathology during the early stages of a 
recall response. WT and Ccr5/ Cxcr3/ 
mice were infected with 3000 EID50 x31 in-
fluenza virus and allowed to rest for 90 d. 
Mice were then challenged with 50 LD50 PR8 
influenza virus and sacrificed at the indi-
cated times after challenge. (A) Viral titers in 
the lungs of WT (open circles) and Ccr5/ 
Cxcr3/ mice (red circles) were measured at 
days 2, 4, 6, and 8 after challenge by plaque 
assay, and the dotted line indicates the limit 
of detection. Each symbol represents and 
individual mouse and the lines represent  
the geometric mean ± SD (*, P < 0.05).  
(B and C) Lung sections from WT (white bars) 
and Ccr5/ Cxcr3/ mice (red bars) were 
scored for perivascular (top graph) and peri-
bronchial (bottom graph) inflammation on 
days 0, 3, 7, and 14 after challenge (mean ± SD; 
*, P < 0.05). Representative sections for WT 
(left column) and Ccr5/ Cxcr3/ mice 
(right column) are shown in C. Bars, 500 µm. 
The data are representative of 3 independent 
experiments with 5 mice per group (A) and  
2 independent experiments with 10 mice per 
group (B and C). o
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present (Fig. 5 A, middle and bottom 
rows). However, examination of the 
interstitial spaces away from the con-
ducting airways revealed more Cxcr3/ 
and Ccr5/ Cxcr3/ than WT cells 
(Fig. 5 B). Thus, both Cxcr3/ and 
Ccr5/ Cxcr3/ cells in the lung appear to preferentially 
localize in the interstitial spaces distant from the site of 
viral replication.
To assess whether the differential localization of WT and 
chemokine-receptor deficient cells in the lung resulted in 
these cells receiving different activation signals, we examined 
expression of the activation marker CD69 using mixed BM 
chimeras. As shown in Fig. 6 (A and B), CD69 expression in 
the bronchoalveolar lavage (BAL), mediastinal lymph node 
(MLN), and spleen was similar between WT, Ccr5/, 
Cxcr3/, and Ccr5/ Cxcr3/ cells. In contrast, signifi-
cantly fewer Cxcr3/ and Ccr5/ Cxcr3/ cells expressed 
CD69 compared with WT and Ccr5/ cells in the lung, 
suggesting that these cells were not exposed to antigen and/or 
inflammation caused by differential localization within the 
tissue. Because we observed differential activation of WT and 
Ccr5/ Cxcr3/ cells in the lung, and activation-induced 
cell death is a major mechanism that contributes to T cell 
contraction after pathogen clearance (Strasser and Pellegrini, 
2004), we investigated whether there was a differential sus-
ceptibility to apoptosis by measuring caspase activity in 
FluNP366-374Db-specific cells from the lung. As shown in Fig. 6 
(C and D), Ccr5/ Cxcr3/ cells show decreased caspase 
activity compared with WT cells on days 10–14 after infection. 
Furthermore, the detectable caspase activity was largely restricted 
to the CD69+ population in both WT and Ccr5/ Cxcr3/ 
cells. Together, these data suggest that chemokine-directed 
localization of FluNP366-374Db-specific CD8+ T cells within 
the days after clearance. As expected, both populations of 
cells show a gradual decrease in BrdU incorporation after 
viral clearance (Fig. 4, C and D). However, WT cells showed 
equivalent, and in some cases enhanced, BrdU uptake in all 
tissues between days 10–14 after infection compared with 
Ccr5/ Cxcr3/ cells (Fig. 4, C and D). Thus, increased 
proliferation does not account for the outgrowth of Ccr5/ 
Cxcr3/ FluNP366-374Db-specific CD8+ T cells immediately 
after viral clearance.
Previous studies of T cell trafficking during respiratory 
virus infection have shown that CCR5 and CXCR3 play 
distinct, nonoverlapping roles in migration to different com-
partments of the lung. These findings suggest that chemokine 
receptor–deficient cells present in the lung during the acute 
phase of infection may localize to different areas than WT 
cells, and thus would be exposed to a different local environ-
ment and different stimuli. To test this hypothesis, we trans-
ferred equal numbers of FluNP366-374Db-specific WT and 
Ccr5/, Cxcr3/, or Ccr5/ Cxcr3/ memory T cells into 
naive congenic (CD90.1+ CD45.2+) hosts and their localiza-
tion within the lung was visualized by microscopy on day 10 
after infection (Fig. 5). Around large conducting airways, 
where influenza virus infection and replication are commonly 
localized, there is a similar accumulation of WT (CD45.1+ 
CD90.2+) and Ccr5/ (CD45.1 CD90.2+) cells (Fig. 5 A, 
top row). In contrast, mice receiving a mixture of WT and 
Cxcr3/ or Ccr5/ Cxcr3/ cells showed mostly WT cells 
accumulating around the large airways, with few KO cells 
Figure 3. Increased numbers, and de-
creased contraction, of Ccr5/ Cxcr3/ 
T cells in all tissues after influenza infec-
tion. Mixed BM chimeras were infected with 
PR8 influenza virus and sacrificed at the indi-
cated times. (A) The number of FluNP366-374Db-
specific WT (black) and Ccr5/ Cxcr3/ (red) 
T cells in the indicated tissues is graphed as 
the mean ± SD (*, P < 0.05; **, P < 0.005; ***,  
P < 0.0005). (B) The fold contraction of WT 
(black) and Ccr5/ Cxcr3/ (red) FluNP-
specific T cells comparing day 10 to day 120 
after infection (mean ± SD). The numbers 
show the difference in fold contraction be-
tween WT and Ccr5/ Cxcr3/ cells. (C) The 
phenotype of WT (black) and Ccr5/ Cxcr3/ 
(red) memory CD8+ T cells on day 60 after 
infection. Plots are gated on FluNP366-374Db+ 
cells and representative staining is shown. The 
data are representative of four independent 
experiments with at least five mice per  
time point.
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Chemokine receptors influence  
the activation and contraction  
of influenza-specific T cells in the lung  
by regulating reencounter  
with antigen
The decreased activation and differen-
tial localization of Ccr5/ Cxcr3/ 
cells in the lung compared with WT cells was consistent with 
the idea that Ccr5/ Cxcr3/ cells were unable to reencoun-
ter antigen in the lung and thus failed to contract after viral 
clearance. To test this idea, we devised an approach to force 
Ccr5/ Cxcr3/ cells to recognize their cognate antigen 
by repeated injections of antigen-bearing DCs (Fig. 7 A; 
FluNP). As a control, we injected the same DCs into a paral-
lel cohort of mice, except these DCs had been pulsed with an 
irrelevant antigen (p79). As shown in Fig. 7 (B and C), injec-
tion of FluNP-pulsed DCs resulted in significantly increased 
CD69 expression on Ccr5/ Cxcr3/ cells in the lung, 
whereas p79-pulsed DCs had no effect. Importantly, 45 d after 
infection, mice that had received FluNP-pulsed DCs had a 
decreased frequency of influenza-specific Ccr5/ Cxcr3/ 
T cells compared with mice that had received p79-pulsed 
DCs (Fig. 7 D). This difference correlated with a significant 
decrease in the number of FluNP366-374Db-specific Ccr5/ 
Cxcr3/ T cells in both the lung and spleen in mice that had 
received FluNP-pulsed DCs (Fig. 7 E). Collectively, these 
data show that the addition of excess antigen leads to the ac-
tivation, contraction, and decreased memory generation of 
Ccr5/ Cxcr3/ CD8+ T cells. Therefore, chemokine re-
ceptors influence the generation of T cell memory after re-
spiratory infection by controlling cellular localization and 
antigen reencounter in the lung, thereby altering effector 
versus memory cell–fate decisions.
the lung parenchyma dictates which cells are able to re-
encounter antigen, which influences activation-induced cell 
death and regulates antigen-specific T cell contraction after 
pathogen clearance.
During acute infection, expression patterns of the IL-7R 
chain, CD127, and KLRG-1 identifies pathogen-specific 
CD8+ T cells that preferentially survive to become long-
lived memory T cells (Kaech et al., 2003). To investigate 
whether the chemokine receptor–deficient FluNP366-374Db-
specific populations contained increased numbers of mem-
ory precursors compared with the WT population, we 
used mixed BM chimeras to analyze CD127 and KLRG-1 
expression in multiple tissues. As shown in Fig. 6, although 
CD127 expression on FluNP366-374Db-specific cells was similar 
between WT and chemokine receptor–deficient cells at day 
10 after infection, there was a significant increase in fre-
quency of CD127+ FluNP366-374Db-specific Cxcr3/ and 
Ccr5/ Cxcr3/ cells compared with WT and Ccr5/ 
cells by day 15 after infection. Furthermore, the difference in 
CD127 expression occurred almost immediately after clear-
ance, and even in an inflamed site such as the lung (Fig. 6, 
E and F). Thus, after viral clearance, both Cxcr3/ and 
Ccr5/ Cxcr3/ cells rapidly progress to MPEC pheno-
type, as shown by significantly increased CD127 expression, 
which is consistent with attenuated contraction and en-
hanced memory.
Figure 4. The rapid outgrowth of 
Ccr5/ Cxcr3/ FluNP-specific CD8+  
T cells after viral clearance is not caused by 
enhanced proliferation. Mixed BM chimeras 
were infected with PR8 influenza virus and 
sacrificed at the indicated times after infec-
tion. (A) Representative FluNP366-374Db tetra-
mer staining in the spleen for Ccr5/ 
Cxcr3/ (top row) and WT (bottom row) cells 
on days 10, 12, and 14 after infection. Plots 
are gated on CD8+ T cells. (B) The frequency of 
WT (black) and Ccr5/ Cxcr3/ (red) FluNP-
specific cells among CD8+ T cells in the BAL, lung, 
MLN, and spleen is graphed as the mean ± SD  
(*, P < 0.05; **, P < 0.005). (C) Representative 
staining of BrdU uptake in WT and Ccr5/ 
Cxcr3/ cells in the lung on day 12 after 
infection. (D) The frequency of BrdU+ cells 
among WT (black) or Ccr5/ Cxcr3/ (red) 
FluNP-specific cells in the BAL, lung, MLN, and 
spleen (mean ± SD). The data are representa-
tive of three independent experiments with at 
least four mice per time point.
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WT and Ccr5/ Cxcr3/ Mtb10.44-11Kb-specific cells were 
observed in the lung (Fig. 8 A), MLN (Fig. 8 B), and spleen 
(Fig. 8 C). However, the Mtb10.44-11Kb-specific population 
was gradually skewed in favor of Ccr5/ Cxcr3/ cells as 
the infection progressed (Fig. 8 D). Notably, the preferential 
accumulation of Ccr5/ Cxcr3/ cells occurred after day 30 
of infection, after which bacterial levels stabilize and chronic 
infection is maintained at relatively constant level (Flynn, 
2006). Therefore, even in a situation where antigen and in-
flammation persist, the Mtb10.44-11Kb-specific CD8+ T cell 
pool becomes increasingly dominated by Ccr5/ Cxcr3/ 
cells over time.
One explanation to account for the outgrowth of Ccr5/ 
Cxcr3/ cells during chronic infection is that the inability of 
these cells to properly migrate limits their exposure to inflam-
mation and antigen, which prevents or slows their terminal 
Preferential expansion of Ccr5/ Cxcr3/ cells  
during chronic Mtb infection
Chronic infections, which are often characterized by persis-
tent inflammation and antigen expression, have a profound 
effect on the accumulation and functionality on the pathogen-
specific CD8+ T cell pool (Shin and Wherry, 2007). For 
example, in patients with active Mtb infection, the pathogen-
specific CD8+ T cell pool is dominated by effector cells 
expressing a terminally differentiated phenotype (Jacobsen 
et al., 2007; Jurado et al., 2008). We questioned whether, even 
during chronic infection, Ccr5/ Cxcr3/ cells would be 
much less prone to terminal differentiation and exhaustion 
caused by decreased migration to inflamed areas. To test this 
hypothesis, we tracked the CD8+ T cell response to a domi-
nant Mtb epitope over time in mixed BM chimeras (Fig. 8). 
During the early stages of infection, similar frequencies of 
Figure 5. Differential localization of Cxcr3/ and Ccr5/ Cxcr3/ cells in the lung. The localization of WT (CD45.1+ CD90.2+) and Ccr5/ 
(CD45.1 CD90.2+) cells (top row), WT and Cxcr3/ cells (middle row), and WT and Ccr5/ Cxcr3/ cells (bottom row) around large conducting airways 
(A) or in the interstitium (B) on day 10 of an influenza infection. Collagen IV staining is shown to visualize lung morphology. Bars, 100 µm. The data are 
representative of three independent experiments with at least four mice per group.
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Thus, Ccr5/ Cxcr3/ Mtb10.44-11Kb-specific CD8+  
T cells showed limited activation caused by antigen and/or 
inflammation, which protected these cells from terminal dif-
ferentiation and enabled their accumulation even during a 
chronic infection.
DISCUSSION
Chemokine receptors have been shown to play an important 
role in many inflammatory situations, primarily through their 
role in directing cellular migration. Recent studies have 
differentiation. To address this possibility, we examined ex-
pression of the activation markers CD69 and CD127 on 
Mtb10.44-11Kb-specific WT and Ccr5/ Cxcr3/ cells over 
time. As shown in Fig. 9 (A and B), significantly fewer 
Ccr5/ Cxcr3/ cells expressed CD69 compared with WT 
cells in all tissues examined, and this difference became greater 
as the infection progressed. Strikingly, and similar to influ-
enza infection, decreased expression of the acute activation 
marker CD69 correlated with increased expression of CD127 
even at late times during chronic infection (Fig. 9, C and D). 
Figure 6. Decreased activation of Cxcr3/ and Ccr5/ Cxcr3/ FluNP-specific cells in the lung compared with WT and Ccr5/ cells cor-
relates with the rapid appearance of CD127hi memory precursor cells. Mixed BM chimeras were infected with PR8 influenza virus and sacrificed at 
the indicated times. (A) The expression of CD69 on WT (black), Ccr5/ (green), Cxcr3/ (blue), and Ccr5/ Cxcr3/ (red) FluNP-specific cells was mea-
sured by flow cytometry. The histograms show representative staining gated in FluNP366-374Db+ CD8+ T cells. (B) The frequency of CD69+ cells among 
FluNP-specific CD8+ T cells in the BAL, lung, MLN, and spleen on days 10, 12, and 14 after infection (mean ± SD; **, P < 0.005; ***, P < 0.0005). The WT 
data shown are from the WT × Ccr5/ Cxcr3/ mixed BM chimera, and similar data were obtained from WT in the other chimeras. (C) Representative 
staining of pan-caspase activity in Ccr5/ Cxcr3/ (top row) and WT (bottom row) FluNP-specific CD8+ T cells from the lung after a 1-h incubation in 
vitro. The data are gated on FluNP366-374Db+ cells and plotted versus CD69. (D) The frequency of FLICA+ WT (black) or Ccr5/ Cxcr3/ (red) FluNP-specific 
cells in the lung on days 10, 12, and 14 after infection (mean ± SD; *, P < 0.05; **, P < 0.005; ***, P < 0.0005). (E) Representative staining of CD127 versus 
KLRG1 on WT and KO cells from various mixed BM chimeras. Staining is shown gated on FluNP366-374Db+ CD8+ T cells in the lung on day 15 after infection. 
(F) The frequency of CD127+ cells among WT, Ccr5/, Cxcr3/, or Ccr5/ Cxcr3/ FluNP-specific CD8+ T cells in the indicated tissues on days 10, 15, 
and 21 after infection (mean ± SD; *, P < 0.05, **; P < 0.005; ***, P < 0.0005). The data are representative of three independent experiments with at least 
four mice per time point.
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CCR5 in the enhancement of T cell memory. These find-
ings illustrate a new role for inflammatory chemokine recep-
tors in regulating T cell memory generation through their 
control of T cell localization within infected tissues.
Many studies have focused on deciphering the signals that 
promote the generation of T cell memory after infection or 
vaccination. Signals that have the potential to influence cell 
fate decisions act at nearly every step of T cell activation, 
from initial TCR triggering and cell division to environmen-
tal signals received after pathogen clearance.
These efforts have led to the development of several 
models to describe the cell fate decisions that control effector 
versus memory commitment (Kaech and Wherry, 2007). 
One model in particular, which posits that the commitment 
shown that the localization of CD8+ T cells to distinct micro-
environments during infection can have a dramatic impact on 
their differentiation and ultimately determine effector versus 
memory T cell fate (D’Cruz et al., 2009). In this study, we 
demonstrate that chemokine receptor–directed localization 
of effector T cells within infected tissues had a profound im-
pact on their activation state and their ability to progress onto 
memory. After influenza virus infection, antigen-specific 
CD8+ T cells in the lung that lacked the inflammatory che-
mokine receptors CCR5 and CXCR3 showed decreased 
activation, were protected from apoptosis, and were largely 
resistant to contraction, leading to the generation of massive 
amounts of CD8+ T cell memory. This phenotype was pri-
marily dependent on CXCR3, although there was a role for 
Figure 7. Cognate antigen encounter is sufficient to induce the activation of Ccr5/ Cxcr3/ T cells in the lung and lead to the contrac-
tion of FluNP-specific cells. (A) Mixed BM chimeras were infected with PR8 influenza virus and injected i.v. with 2 × 106 DCs pulsed with cognate 
(FluNP) or irrelevant (HV p79) peptide on days 10 and 12 after infection. (B) Representative staining of CD69 on Ccr5/ Cxcr3/ (top row) and WT 
(bottom row) FluNP-specific cells in the lung on day 13 after infection, after transfer of p79- or FluNP-pulsed DCs. (C) The frequency of CD69+ cells after 
DC transfer is graphed as the mean ± SD (*, P < 0.05). (D) Representative FluNP366-374Db tetramer staining of Ccr5/ Cxcr3/ (top row) and WT (bottom 
row) cells from the lung and spleen on day 45 after infection (33 d after the last DC transfer). Plots are gated on CD8+ T cells. (E) The number of FluNP-
specific WT (black) and Ccr5/ Cxcr3/ (red) T cells in the lung and spleen at day 45 after infection (the mean ± SD; *, P < 0.05; **, P < 0.005). The data 
are representative of two independent experiments with at least five mice per group.
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A recent study has highlighted the importance of cellular 
localization in controlling access to these signals, as cells with 
a terminally differentiated phenotype were localized to a dif-
ferent area of the spleen than cells with a memory precursor 
phenotype after LCMV infection (Jung et al., 2010). Our 
data suggest a model where, after initial priming and prolifer-
ation in the draining lymph nodes, effector T cells migrate to 
the lung, where they reencounter antigen and undergo fur-
ther differentiation. Unlike WT cells, which follow chemo-
tactic gradients to the inflamed site, Cxcr3/ or Ccr5/ 
Cxcr3/ cells are preferentially localized to the interstitial 
spaces away from the primary sites of viral replication (respi-
ratory epithelial cells lining the large airways), and the lack of 
additional stimuli promotes the progression of these cells into 
memory. However, we can artificially induce the activation 
and contraction of chemokine receptor–deficient cells through 
the addition of excess antigen, thereby forcing these cells to 
recognize antigen regardless of their localization. Thus, anti-
gen reencounter in the lung controls effector versus memory 
cell fate decisions during influenza virus infection, and access 
to this antigen in the lung is regulated by chemokine-mediated 
cell trafficking. It should be noted that there may be addi-
tional antigen-independent signals that Cxcr3/ or Ccr5/ 
Cxcr3/ cells fail to receive because of improper localization 
during initial priming in lymphoid tissues. Indeed, the ac-
companying article by Kurachi et al. in this issue of the JEM 
shows that CXCR3 regulates T cell fate decisions during sys-
temic infection by regulating the proximity of T cells to inflam-
matory cytokines during the early expansion phase. Together, 
these studies suggest that CXCR3-mediated trafficking may 
influence T cell memory generation at multiple stages of the 
adaptive immune response, and raise the possibility that the 
primary mechanisms by which CXCR3 regulates T cell fate 
(i.e., access to antigen and/or inflammation) may depend 
on whether the host is responding to a localized versus 
systemic infection.
A role for inflammatory chemokine receptors in promot-
ing initial CD8+ T cell priming has been recently demon-
strated. Within the lymph node, chemokine secretion by 
activated dendritic cells can attract CD8+ T cells in a CCR5- 
or CCR4-dependent manner to promote T cell–dendritic 
cell contacts (Castellino et al., 2006; Semmling et al., 2010). 
In addition, several studies have noted a role for chemokine 
receptor–mediated signals in augmenting T cell activation ir-
respective of their role in T cell migration. CXCR3 ligands 
have been shown to enhance T cell receptor signaling during 
priming and induce mammalian target of rapamycin (mTOR) 
activation (Newton et al., 2009; Rosenblum et al., 2010; 
Schwarz et al., 2009). Based on these data, it is possible that 
certain chemokine receptor–dependent signals not being re-
ceived by Cxcr3/ or Ccr5/ Cxcr3/ cells during priming 
may influence the progression of these cells to memory. 
However, if this were true, the decreased activation (as mea-
sured by CD69 expression) of Cxcr3/ and Ccr5/ Cxcr3/ 
cells compared with WT cells would be observed in all tis-
sues. Instead, we only observe decreased CD69 expression in 
of cells to an effector or memory T cell fate is initially pro-
grammed at an early stage of differentiation but can be subse-
quently altered if additional stimuli (antigen or inflammation) 
are encountered, fits nicely with our data. After initial anti-
gen encounter in the lung-draining lymph nodes, CD69–
S1P1 interactions keep activated cells from leaving the lymph 
node until a sufficient number of cell divisions have occurred 
(Lawrence and Braciale, 2004; Shiow et al., 2006). Our data 
show no difference in this initial response between WT and 
Ccr5/ Cxcr3/ cells, as we observe no difference in the 
number of FluNP-specific cells, or in expression of CD69, 
within the lymph nodes during the early stages of influenza 
virus infection (Fig. 3 A and Fig. 6 B). However, after migra-
tion through the circulation and into the lung, we observe a 
dramatic difference in the activation of WT and Ccr5/ 
Cxcr3/ FluNP-specific cells, which correlates with a differ-
ence in apoptosis and memory generation. These data are consis-
tent with the aforementioned model of differentiation, where 
additional encounters with antigen and/or inflammatory stimuli 
push antigen-specific T cells to a terminally differentiated state. 
Figure 8. Ccr5/ Cxcr3/ cells dominate the antigen-specific 
response even during chronic Mtb infection. Mixed BM chimeras were 
infected with Mtb via the aerosol route and sacrificed at the indicated 
times. (A–C) Representative staining of Mtb10.44-11Kb tetramer on Ccr5/ 
Cxcr3/ (top row) and WT (bottom row) cells from the lung (A), MLN (B), 
and spleen (C) on day 25 or 90 after infection. Plots are gated on CD8+  
T cells. (D) The frequency of WT (black) or Ccr5/ Cxcr3/ (red) Mtb-
specific CD8+ T cells in the lung, MLN, and spleen at the indicated times after 
infection (mean ± SD; *, P < 0.05; **, P < 0.005). The data are representa-
tive of two independent experiments with at least four mice per group.
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been previously shown that Mtb-specific 
memory CD8+ T cells do develop during 
the infection, and antibiotic clearance of 
the bacteria allows for effector CD8+  
T cell contraction and the outgrowth of 
these Mtb-specific memory cells (Kamath 
et al., 2006). Similar to other chronic 
pathogens, Mtb-specific CD8+ T cells 
from patients show enhanced expression 
of programmed death 1, suggesting that 
these cells receive continual antigen stim-
ulation (Jurado et al., 2008). In mice, the 
continual stimulation of CD8+ T cells during Mtb infection is 
suggested by the close association of CD8+ T cells with estab-
lished granulomas in the lungs of chronically infected mice 
(Junqueira-Kipnis et al., 2004). It is possible that, similar to 
what we observed during influenza infection, Ccr5/ Cxcr3/ 
cells fail to migrate to the most inflamed areas, in this case the 
granuloma, and are therefore spared from chronic antigen en-
counter. This would explain both the lack of CD69 expression 
and the enhanced CD127 expression on Ccr5/ Cxcr3/ 
Mtb10.44-11Kb-specific CD8+ T cells, and we are currently in-
vestigating this possibility in more detail.
Because the ability of pathogen-specific CD8+ T cells to 
carry out their cytolytic functions depends on their ability 
to migrate to the infected site, the permanent inhibition of 
CCR5- and CXCR3-mediated signaling would likely be 
counter-productive to host fitness. Indeed, intact chemokine 
receptor–deficient mice are significantly more susceptible to 
PR8 influenza infection than WT mice (Fig. S1). However, 
our data suggest that temporarily inhibiting or dampening 
the lung (Fig. 6 A), which supports our conclusion that 
chemokine-directed localization, rather than chemokine-
 mediated signals unrelated to cell migration, is responsible for 
the enhanced generation of T cell memory in our model. Our 
data clearly show that the decreased activation of influenza-
specific T cells in the lung is primarily dependent on CXCR3, 
but not CCR5. Nevertheless, it is clear there is a considerable 
increase in the frequency and number of memory T cells in 
the absence of both CCR5 and CXCR3 when compared 
with CXCR3 alone (Fig. 1 and Fig. S2). As there is consider-
able redundancy in the chemokine system, it is possible that 
a role for CCR5 in memory T cell generation only becomes 
manifest in the absence of CXCR3. We are currently inves-
tigating this possibility to delineate the relative contributions 
of these two chemokine receptors in our model.
An especially intriguing finding is that even during chronic 
infection with Mtb, which is associated with high levels of 
persistent inflammation, antigen-specific Ccr5/ Cxcr3/ 
cells still display a quiescent, resting phenotype (Fig. 9). It has 
Figure 9. Mtb-specific Ccr5/ Cxcr3/ 
cells show decreased activation and enhanced 
CD127 expression during chronic infection. 
Mixed BM chimeras were infected with Mtb via 
the aerosol route and sacrificed at the indicated 
times. (A) Representative staining of Mtb10.44-11Kb 
tetramer and CD69 on Ccr5/ Cxcr3/ (top row) 
and WT (bottom row) cells in the lung on day 25 
or 90 after infection. Plots are gated on CD8+  
T cells. (B) The frequency of CD69+ WT (black) or 
Ccr5/ Cxcr3/ (red) Mtb-specific CD8+ T cells 
in the lung, MLN, and spleen at the indicated 
times after infection (mean ± SD; *, P < 0.05;  
**, P < 0.005; ***, P < 0.0005). (C) Representative  
staining of Mtb10.44-11Kb tetramer and CD127 on 
Ccr5/ Cxcr3/ (top row) and WT (bottom row) 
cells in the spleen on day 25 or 90 after infection. 
Plots are gated on CD8+ T cells. (D) The frequency 
of CD127+ WT (black) or Ccr5/ Cxcr3/ (red) 
Mtb-specific CD8+ T cells in the lung, MLN, and 
spleen at the indicated times after infection 
(mean ± SD; *, P < 0.05; **, P < 0.005;  
***, P < 0.0005). The data are representative of 
two independent experiments with at least four 
mice per group.
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50 ng/ml LPS for 18 h to stimulate cells. For the last 3 h of culture, 
BM-derived DCs were pulsed with 10 µg/ml of FluNP366-374 or HV 
p79524-531 peptide.
Tissue harvest and flow cytometry. Mice were sacrificed at the indi-
cated times and tissues were harvested and processed as previously described 
(Kohlmeier et al., 2010). Single-cell suspensions were incubated with 
Fc-block (anti-CD16/32) for 15 min on ice, followed by staining with 
FluNP366-374Db or Mtb10.44-11Kb tetramers for 1 h at room temperature. 
Cells were then washed and stained with antibodies to CD8, CD44, CD45.1, 
CD45.2, CD69, and CD127 (eBioscience); CD8, CD27, CD62L, and 
CD69 (BD); CD43 (1B11), CD62L, and CD90.2 (BioLegend); and KLRG1 
(SouthernBiotech). Samples were run on FACSCalibur, FACSCanto II, or 
LSR II flow cytometers (BD) and data were analyzed with FlowJo software 
(Tree Star).
Adoptive transfer and immunofluorescence microscopy. Mixed BM 
chimeras were infected with x31 influenza and rested for 45 d. WT, Ccr5/, 
Cxcr3/, and Ccr5/ Cxcr3/ effector memory T cells (CD45.2+/ 
CD44hi CD62Llo) were sorted from the spleen. Sorting was performed on a 
FACSVantage cell sorter with DiVa electronics (BD). Aliquots of the sorted 
cells were stained with FluNP366-374Db tetramer to determine the total num-
ber of FluNP-specific cells in each population, and the populations were 
mixed together such that the ratio of FluNP-specific WT and chemokine 
receptor–deficient cells was 1:1. This mixture was transferred i.v. into a con-
genic (CD90.1+) host, and the host was infected with PR8 influenza 1 d later. 
On day 10 after infection, lungs were inflated with OCT (Sakura Finetek) 
and snap-frozen over liquid nitrogen. Frozen sections (7 µm) were fixed in 
acetone/ethanol and stained with antibodies against collagen type IV (R&D 
Systems), CD45.1-PE, and CD90.2-Alexa Fluor 647. Rabbit anti–mouse 
collagen type IV was detected with a goat anti–rabbit-Alexa Fluor 488 sec-
ondary antibody (Invitrogen). Staining was visualized with a Zeiss AxioVert 
200M microscope using a 20× 0.75 na objective, and images were recorded 
with an AxioCam digital camera (Carl Zeiss, Inc.). Images were analyzed and 
converted to TIF files with AxioVision software (Carl Zeiss, Inc.).
Assessment of caspase activity. Caspase activity was assessed using the 
Vybrant FAM Poly Caspases Assay kit according to the manufacturer’s in-
structions (Invitrogen). In brief, whole-lung homogenates were incubated at 
37°C for 1 h in the presence of FAM-VAD-FMK poly caspases reagent. 
After incubation, cells were stained with tetramers and antibodies for flow 
cytometry as described above.
Measurement of BrdU uptake. Mice were administered BrdU (200 µl 
of a 4 mg/ml solution in PBS) i.p. and maintained on drinking water 
containing BrdU (0.8 mg/ml) for 24 h before harvest. Single-cell suspen-
sions were stained with tetramers and antibodies to surface proteins as 
described above and BrdU incorporation was detected using the BrdU 
Flow kit (BD).
Measurement of virus titers. Whole-lung tissue was harvested in PBS at 
the indicated times, and lung homogenates were stored at 70°C. Virus 
titers were measured using a standard plaque assay by infecting MDCK cell 
monolayers with serial 10-fold dilutions of lung suspension in duplicate. 
24 h after infection, monolayers were extensively washed and fixed with 80% 
acetone in water. Infected cell clusters were detected with a biotin-labeled 
mouse antiinfluenza A monoclonal antibody (Millipore), followed by stain-
ing with streptavidin-AP and visualized with Fast BCIP/NBT substrate 
(Sigma-Aldrich). The number of PFU were counted, and the data were 
shown as the PFU/lung (mean ± SD).
Histological analysis. Lungs were inflated with 5 ml neutral buffered for-
malin (10% vol/vol) via the trachea and fixed for 72 h. Lungs were embedded 
in paraffin wax, and 4–5-µm sections were mounted onto slides and stained 
with hematoxylin and eosin. The inflammatory score (on a scale of 0–4) was 
these signals after vaccination may prove an effective tech-
nique for generating large numbers of robust memory T cells. 
Currently, there are several small molecule inhibitors directed 
against CCR5 and/or CXCR3 that have the potential to 
temporarily inhibit T cell migration during vaccination and 
may provide a means to increase vaccine efficacy (Proudfoot 
et al., 1996; Akashi et al., 2005; Rosenblum et al., 2009). For 
example, although peptide vaccination with a highly inflam-
matory adjuvant, such as complete Freund’s adjuvant, usually 
generates memory CD8+ T cells that show hallmarks of ter-
minal differentiation and poor recall responses (Hikono et al., 
2007), vaccinating while limiting the continual stimulation of 
antigen-specific T cells by inhibiting their migration to in-
flammatory chemokines may enhance both the number and 
quality of the T cell memory generated. This may be espe-
cially important for vaccination against certain pathogens, 
such as malaria, where abnormally high numbers of antigen-
specific CD8+ T cells are required for protection (Schmidt 
et al., 2008).
In conclusion, we describe a novel role for the inflamma-
tory chemokine receptors CCR5 and CXCR3 in the gener-
ation of CD8+ T cell memory. Pathogen-specific Cxcr3/ 
and Ccr5/ Cxcr3/ cells are preferentially localized to 
noninflamed areas within infected tissues, which limits their 
ability to be reactivated by additional antigen encounters, re-
sulting in greatly enhanced memory CD8+ T cell generation. 
These data suggest that blocking T cell migration in response 
to CCR5 and CXCR3 ligands may enhance the generation 
of T cell memory after vaccination and temporarily inhib-
iting these chemokine receptors during chronic infection 
may enhance the quality of the antigen-specific memory 
T cell pool.
MATERIALS AND METHODS
Mice. Female C57BL/6J, B6.PL-Thy1a/Cy (CD90.1+), B6.SJL-Ptprca 
Pep3/BoyJ (CD45.1+), and B6.129P2-Ccr5tm1Kuz /J (Ccr5/) mice were 
purchased from The Jackson Laboratory. Cxcr3/ and Ccr5/ Cxcr3/ 
double-deficient mice on the B6 background were generous gifts from 
C. Gerard (Harvard Medical School, Boston, MA) and A. Thomsen (University 
of Copenhagen, Copenhagen, Denmark), respectively (de Lemos et al., 
2005; Hancock et al., 2000). Mixed BM chimeras were generated as previ-
ously described (Mayer et al., 2008) and allowed to reconstitute for 6 wk be-
fore infection. All animal studies were approved by the Trudeau Institute 
Animal Care and Use Committee.
Viruses, bacteria, and infections. Influenza viruses A/HK-x31 (x31, 
H3N2) and A/PR8 (PR8, H1N1) were grown, stored, and titered as previ-
ously described (Hou et al., 1992). Mtb strain H37Rv was grown and stored 
as previously described (Reiley et al., 2008). For influenza virus infection, 
mice were anesthetized with 2,2,2-tribromoethanol (200 mg/kg) and virus 
was administered intranasally (500 50% egg infectious doses [EID50] for pri-
mary infections and 3 × 104 EID50 for secondary infections). For aerosol Mtb 
infection, animals were infected with a low dose (75 CFU) of bacteria by 
using a Glas-Col airborne infection system.
Generation of BM-derived DCs. Single-cell suspensions of BM from 
C57BL/6J mice were cultured at 2 × 106 cells in RPMI containing 10% 
FCS, 100 U/ml penicillin and streptomycin, and 20 ng/ml of GM-CSF. 
Cultures were given fresh medium every 2–3 d, and incubated at 37°C for 10 d. 
On day 9, BM-derived DCs were resuspended in fresh medium containing 
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